Literature DB >> 8263843

Thrombocytopenia in cats: a retrospective study of 41 cases.

H L Jordan1, C B Grindem, E B Breitschwerdt.   

Abstract

The prevalence of feline thrombocytopenia (< 200,000 platelets/microL) at North Carolina State University, College of Veterinary Medicine Teaching Hospital, from January 1985 to March 1990, was 1.2% (41/3300). Cats were divided into six categories based on clinical diagnoses: 29% (12/41) had infectious disease, 20% (8/41) had neoplasia, 7% (3/41) had cardiac disease, 2% (1/41) had primary immune-mediated disease, 22% (9/41) had multiple diseases, and 20% (8/41) had disorders of unknown etiology. The mean platelet count for all thrombocytopenic cats was 52,000/microL +/- 46,000/microL (1 SD) with a range of 1000-190,000/microL. No significant differences were found between groups with respect to platelet count, packed cell volume, or white blood cell count, though anemia and leukopenia were common among the cats as a whole. Bleeding disorders (hemorrhage or thrombosis) were observed in 29% (12/41) of thrombocytopenic cats and were more likely to be associated with neoplasia, cardiac disease, and platelet counts less than or equal to 30,000/microL. Disseminated intravascular coagulopathy was diagnosed in 12% (5/41) of the cats. Infections and/or neoplasia affecting the bone marrow were the most common diseases associated with thrombocytopenia. Feline leukemia virus and myeloproliferative neoplasia accounted for approximately 44% (18/41) of the specific diagnoses in thrombocytopenic cats.

Entities:  

Mesh:

Year:  1993        PMID: 8263843     DOI: 10.1111/j.1939-1676.1993.tb01017.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  4 in total

1.  Platelet-bound antibodies detected by a flow cytometric assay in cats with thrombocytopenia.

Authors:  Barbara Kohn; Tanja Linden; Wolfgang Leibold
Journal:  J Feline Med Surg       Date:  2006-04-17       Impact factor: 2.015

2.  2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1- Defining populations at risk.

Authors:  Armelle deLaforcade; Lenore Bacek; Marie-Claude Blais; Corrin Boyd; Benjamin M Brainard; Daniel L Chan; Stefano Cortellini; Robert Goggs; Guillaume L Hoareau; Amy Koenigshof; Ron Li; Alex Lynch; Alan Ralph; Elizabeth Rozanski; Claire R Sharp
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2022-05-02

3.  Study on the kinetics and influence of feline platelet aggregation and deaggregation.

Authors:  Barbara Riond; Andrea Katharina Waßmuth; Sonja Hartnack; Regina Hofmann-Lehmann; Hans Lutz
Journal:  BMC Vet Res       Date:  2015-11-05       Impact factor: 2.741

Review 4.  Updates on Laboratory Evaluation of Feline Cardiac Diseases.

Authors:  Alessandra Gavazza; Andrea Marchegiani; Lorenza Guerriero; Vanessa Turinelli; Andrea Spaterna; Sara Mangiaterra; Livio Galosi; Giacomo Rossi; Matteo Cerquetella
Journal:  Vet Sci       Date:  2021-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.